Medically reviewed by Nicholas R. Metrus, MD Huntington’s disease is a hereditary disorder that causes a progressive decline ...

Vesicular monoamine transporter 2 (VMAT2) inhibitors are a type of medication used to manage a specific type of motor symptom in Huntington’s disease known as chorea. Chorea refers to the ...

SOM3355 (bevantolol hydrochloride) hit its objectives in a phase 2 trial in patients with Huntington's disease, improving the involuntary, jerky movements known as chorea that are a key symptom of ...

Neurocrine (NBIX) Biosciences presented data from the KINECT-HD study showcasing significant improvements in chorea across body regions with once-daily INGREZZA capsules in adults with Huntington ...

Huntington's disease (HD) is a hereditary neurodegenerative ... The movement disorder is characterized by involuntary movements known as chorea, and by the impairment of voluntary movements. The ...

Drug Significantly Reduces Chorea Symptoms in Patients With Huntington's Disease May 19, 2023 — The drug valbenazine statistically improves chorea, a movement disorder commonly associated with ...